Russell B. Richerson
Plus aucun poste en cours
Profil
Russell B.
Richerson formerly worked at International Genomics Consortium, as Director from 2011 to 2015, Abbott Laboratories, as Principal, EIDP, Inc., as Principal, Ventana Medical Systems, Inc., as Vice President-Research & Development, Caris Molecular Profiling Institute, Inc., as Chief Operating Officer in 2008, Rebus Holdings, Inc., as COO, Secretary & Principal Accounting Officer from 2016 to 2017, Prometheus Laboratories, Inc., as Vice President-Diagnostic Research & Development in 2004, International Genomics Consortium, as Vice President-Operations, and Boehringer Mannheim Diagnostics Corp., as Principal.
Dr. Richerson received his doctorate degree in 1983 from The University of Texas at Austin and undergraduate degree in 1974 from Louisiana State University.
Anciens postes connus de Russell B. Richerson
| Sociétés | Poste | Fin |
|---|---|---|
| International Genomics Consortium | Directeur/Membre du Conseil | 01/01/2015 |
Caris Molecular Profiling Institute, Inc.
 Caris Molecular Profiling Institute, Inc. Medical/Nursing ServicesHealth Services Caris Molecular Profiling Institute, Inc. provides research and laboratory testing services. It offers tests to help oncologists to understand and treat cancer patients with personalized treatment plans based on the molecular characteristics of their tumors. The company offers services to the hospitals, physicians, and clinical research sponsors. Caris Molecular Profiling Institute was founded on 1996 and is headquartered in Phoenix, AZ. | Directeur des opérations | 01/01/2008 |
| International Genomics Consortium | Corporate Officer/Principal | - |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/2004 |
Boehringer Mannheim Diagnostics Corp.
 Boehringer Mannheim Diagnostics Corp. Medical SpecialtiesHealth Technology Part of Roche Holding AG, Boehringer Mannheim Diagnostics Corp. develops and manufactures personal diagnostic devices. The company is based in Houston, TX. | Corporate Officer/Principal | - |
Formation de Russell B. Richerson
| Louisiana State University | Undergraduate Degree |
| The University of Texas at Austin | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| REBUS HOLDINGS, INC. | Health Technology |
| ABBOTT LABORATORIES | Health Technology |
| Entreprise privées | 6 |
|---|---|
Ventana Medical Systems, Inc.
 Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Electronic Technology |
EIDP, Inc.
 EIDP, Inc. Chemicals: AgriculturalProcess Industries EIDP, Inc. engages in the provision of science-based products and services. It operates through the Seed and Crop Protection segments. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms around the world. The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The company was founded by Eleuthere Irenee du Pont in 1802 and is headquartered in Indianapolis, IN. | Process Industries |
Boehringer Mannheim Diagnostics Corp.
Boehringer Mannheim Diagnostics Corp. Medical SpecialtiesHealth Technology Part of Roche Holding AG, Boehringer Mannheim Diagnostics Corp. develops and manufactures personal diagnostic devices. The company is based in Houston, TX. | Health Technology |
Caris Molecular Profiling Institute, Inc.
Caris Molecular Profiling Institute, Inc. Medical/Nursing ServicesHealth Services Caris Molecular Profiling Institute, Inc. provides research and laboratory testing services. It offers tests to help oncologists to understand and treat cancer patients with personalized treatment plans based on the molecular characteristics of their tumors. The company offers services to the hospitals, physicians, and clinical research sponsors. Caris Molecular Profiling Institute was founded on 1996 and is headquartered in Phoenix, AZ. | Health Services |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Health Technology |
| International Genomics Consortium |
